Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2018-02-08
Product name
FARXIGA TABLETS
Product Synonyms
Forxiga tablets
supplier name
ASTRAZENECA PTY LTD
Emergency telephone
+44 (0) 1235 239 670
Icons in SDS
Company Information
company name
ASTRAZENECA PTY LTD
e-mail address of the competent person responsible for the Safety Data Sheet
SafetyDataSheets.AlderleyPark@astrazeneca.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360, H362, H373
Hazard statements
Code
Statements
H360
May damage fertility or the unborn child
Section 2
2.1 Classification of the substance or mixture
Reproductive toxicity Category 1B Effects on or via lactation Specific target organ toxicity - Category 2 (Kidney, Bone) repeated exposure (Oral)
Signal word
Danger
Hazard statements
H360 May damage fertility or the unborn child. H362 May cause harm to breast-fed children. H373 May cause damage to organs (Kidney, Bone) through prolonged or repeated exposure if swallowed.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust/ fume/ gas/ mist/ vapours/ spray. P264 Wash skin thoroughly after handling. P281 Use personal protective equipment as required.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Hazardous Ingredients
Dapagliflozin
Other hazards which do not result in classification
May cause hypoglycemia. May cause eye irritation. The product may form flammable dust clouds in air, if dust from crushed tablets is allowed to accumulate.
